Variable | Whole cohort | Diabetic nephropathy | Hypertensive nephropathy | GN | ADPKD | Other diseases |
---|---|---|---|---|---|---|
Patient numbers | 743 | 178 | 125 | 86 | 64 | 290 |
Age, years | 68.5 (56.9–77.1) | 66.1 (57.4–74.9) | 76.3 (69.0–81.5) | 62.6 (47.1–72.5) | 54.3 (46.4–63.3) | 71.2 (61.3–78.5) |
Male, n (%) | 462 (62) | 118 (66) | 83 (66) | 55 (64) | 38 (59) | 165 (57) |
Caucasian, n (%) | 695 (94) | 163 (92) | 121 (97) | 79 (92) | 63 (98) | 275 (95) |
Hypertension, n (%) | 723 (97) | 176 (99) | 125 (100) | 85 (99) | 61 (95) | 276 (95) |
Diabetes mellitus, n (%) | 296 (40) | 178 (100) | 33 (26) | 17 (20) | 2 (3) | 66 (23) |
Laboratory values | ||||||
aeGFR, ml/min/1.73m2 | 16 (13–18) | 16 (13–19) | 15 (13–18) | 16 (12–18) | 16 (13–18) | 15 (13–18) |
burine albumin:creatinine ratio, mg/g | 409 (85–1356) | 896 (245–2304) | 172 (43–621) | 1345 (496–2520) | 130 (45–332) | 362 (80–996) |
cCalcium, mg/dL | 9.32 (8.96–9.72) | 9.36 (9.04–9.75) | 9.20 (8.76–9.56) | 9.28 (8.96–9.76) | 9.32 (8.91–9.56) | 9.40 (8.96–9.76) |
cPhosphate, mg/dL | 3.91 (3.41–4.53) | 4.00 (3.44–4.62) | 3.81 (3.32–4.50) | 4.31 (3.60–4.86) | 4.03 (3.57–4.35) | 3.84 (3.32–4.37) |
Bicarbonate, mEq/L | 21.8 (19.6–24.4) | 22.4 (20.3–25.5) | 21.6 (19.7–23.8) | 20.8 (19.2–23.5) | 22.2 (19.1–23.8) | 21.7 (19.4–24.4) |
dAlbumin, g/dL | 4.2 (3.9–4.4) | 4.0 (3.7–4.2) | 4.2 (4.0–4.4) | 4.0 (3.7–4.3) | 4.4 (4.2–4.6) | 4.2 (3.9–4.4) |
KFRE scores | ||||||
4-variable 2-year score, % | 24 (11–42) | 31 (13–53) | 15 (7–30) | 39 (23–66) | 19 (11–33) | 22 (10–36) |
4-variable 5-year score, % | 65 (36–88) | 76 (43–95) | 47 (24–75) | 85 (63–98) | 56 (36–79) | 61 (33–83) |
8-variable 2-year score, % | 20 (10–39) | 23 (12–46) | 15 (7–28) | 31 (18–67) | 18 (9–28) | 19 (9–32) |
8-variable 5-year score, % | 64 (37–89) | 68 (45–94) | 53 (27–77) | 81 (59–99) | 60 (34–78) | 61 (35–82) |